Go Pro
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel Free CL Stock Alerts

Colgate-Palmolive (CL) Financials

Colgate-Palmolive logo
$90.22 -1.73 (-1.88%)
Closing price 08/17/2026 03:58 PM Eastern
Extended Trading
$91.06 +0.84 (+0.93%)
As of 05:07 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Colgate-Palmolive

Annual Income Statements for Colgate-Palmolive

This table shows Colgate-Palmolive's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 1,384 2,441 2,024 2,400 2,367 2,695 2,166 1,785 2,300 2,889 2,132
Consolidated Net Income / (Loss)		 1,548 2,586 2,174 2,558 2,527 2,860 2,338 1,967 2,455 3,049 2,261
Net Income / (Loss) Continuing Operations		 1,548 2,586 2,174 2,558 2,527 2,860 2,338 1,967 2,455 3,049 2,261
Total Pre-Tax Income 		2,763 3,738 3,487 3,464 3,301 3,647 3,087 2,660 3,392 3,956 3,059
Total Operating Income		 2,789 3,955 3,707 3,694 3,554 3,885 3,332 2,893 3,984 4,268 3,306
Total Gross Profit		 9,399 9,123 9,280 9,231 9,325 10,017 10,375 10,248 11,326 12,161 12,251
Total Revenue		 16,034 15,195 15,454 15,544 15,693 16,471 17,421 17,967 19,457 20,101 20,382
Operating Revenue		 16,034 15,195 15,454 15,544 15,693 16,471 17,421 17,967 19,457 20,101 20,382
Total Cost of Revenue		 6,635 6,072 6,174 6,313 6,368 6,454 7,046 7,719 8,131 7,940 8,131
Operating Cost of Revenue		 6,635 6,072 6,174 6,313 6,368 6,454 7,046 7,719 8,131 7,940 8,131
Total Operating Expenses		 6,610 5,168 5,573 5,537 5,771 6,132 7,043 7,355 7,342 7,893 8,945
Selling, General & Admin Expense		 5,464 5,143 5,400 5,389 5,575 6,019 6,407 6,565 7,151 7,729 7,903
Other Operating Expenses / (Income)		 1,146 25 173 148 196 113 65 69 191 164 123
Impairment Charge		 - - - - 0.00 0.00 571 721 0.00 0.00 919
Total Other Income / (Expense), net		 -26 -217 -220 -230 -253 -238 -245 -233 -592 -312 -247
Interest Expense		 26 99 220 143 145 164 175 167 287 292 267
Interest & Investment Income		 - - - - - - - 14 55 67 75
Other Income / (Expense), net		 - -118 - -87 -108 -74 -70 -80 -360 -87 -55
Income Tax Expense		 1,215 1,152 1,313 906 774 787 749 693 937 907 798
Net Income / (Loss) Attributable to Noncontrolling Interest		 164 145 150 158 160 165 172 182 155 160 129
Basic Earnings per Share		 $1.53 $2.74 $2.30 $2.76 $2.76 $3.15 $2.56 $2.13 $2.78 $3.53 $2.64
Weighted Average Basic Shares Outstanding		 902.20M 891.80M 881.80M 870.60M 855.03M 848.56M 840.49M 830.38M 823.15M 811.54M 801.55M
Diluted Earnings per Share		 $1.52 $2.72 $2.28 $2.75 $2.75 $3.14 $2.55 $2.13 $2.77 $3.51 $2.63
Weighted Average Diluted Shares Outstanding		 902.20M 891.80M 881.80M 870.60M 855.03M 848.56M 840.49M 830.38M 823.15M 811.54M 801.55M
Weighted Average Basic & Diluted Shares Outstanding		 902.20M 891.80M 881.80M 870.60M 855.03M 848.56M 840.49M 830.38M 823.15M 811.54M 801.55M
Cash Dividends to Common per Share		 - - $1.59 $1.66 $1.71 $1.75 $1.79 $1.86 $1.91 $2.48 $2.08

Quarterly Income Statements for Colgate-Palmolive

This table shows Colgate-Palmolive's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 718 683 731 737 738 690 743 735 -36 646 693
Consolidated Net Income / (Loss)		 760 729 767 776 777 726 773 766 -4.00 681 719
Net Income / (Loss) Continuing Operations		 760 729 767 776 777 726 773 766 -4.00 681 719
Total Pre-Tax Income 		988 967 1,010 986 993 953 1,007 992 107 892 950
Total Operating Income		 1,072 1,047 1,092 1,065 1,064 1,076 1,080 1,059 91 964 1,016
Total Gross Profit		 2,950 3,039 3,066 3,074 2,982 2,987 3,069 3,049 3,146 3,226 3,296
Total Revenue		 4,950 5,065 5,058 5,033 4,945 4,911 5,110 5,131 5,230 5,324 5,361
Operating Revenue		 4,950 5,065 5,058 5,033 4,945 4,911 5,110 5,131 5,230 5,324 5,361
Total Cost of Revenue		 2,000 2,026 1,992 1,959 1,963 1,924 2,041 2,082 2,084 2,098 2,065
Operating Cost of Revenue		 2,000 2,026 1,992 1,959 1,963 1,924 2,041 2,082 2,084 2,098 2,065
Total Operating Expenses		 1,878 1,992 1,974 2,009 1,918 1,911 1,989 1,990 3,055 2,262 2,280
Selling, General & Admin Expense		 1,803 1,916 1,939 1,979 1,895 1,898 1,963 1,971 2,071 2,076 2,130
Other Operating Expenses / (Income)		 75 76 35 30 23 13 26 19 65 186 150
Total Other Income / (Expense), net		 -84 -80 -82 -79 -71 -123 -73 -67 16 -72 -66
Interest Expense		 - 73 78 74 189 66 71 67 63 62 62
Interest & Investment Income		 - 15 18 18 - 15 21 21 18 16 17
Other Income / (Expense), net		 - -22 -22 -23 - -72 -23 -21 61 -26 -21
Income Tax Expense		 228 238 243 210 216 227 234 226 111 211 231
Net Income / (Loss) Attributable to Noncontrolling Interest		 42 46 36 39 39 36 30 31 32 35 26
Basic Earnings per Share		 $0.86 $0.83 $0.89 $0.90 $0.91 $0.85 $0.92 $0.91 ($0.04) $0.81 $0.87
Weighted Average Basic Shares Outstanding		 823.15M 820.44M 817.09M 817.01M 811.54M 810.42M 808.22M 806.06M 801.55M 800.19M 797.17M
Diluted Earnings per Share		 $0.86 $0.83 $0.89 $0.90 $0.89 $0.85 $0.91 $0.91 ($0.04) $0.80 $0.86
Weighted Average Diluted Shares Outstanding		 823.15M 820.44M 817.09M 817.01M 811.54M 810.42M 808.22M 806.06M 801.55M 800.19M 797.17M
Weighted Average Basic & Diluted Shares Outstanding		 823.15M 820.44M 817.09M 817.01M 811.54M 810.42M 808.22M 806.06M 801.55M 800.19M 797.17M

Annual Cash Flow Statements for Colgate-Palmolive

This table details how cash moves in and out of Colgate-Palmolive's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -119 345 133 -793 157 5.00 -56 -57 191 130 192
Net Cash From Operating Activities		 2,949 3,141 3,054 3,056 3,133 3,719 3,325 2,556 3,745 4,107 4,198
Net Cash From Continuing Operating Activities		 2,949 3,141 3,054 3,056 3,133 3,719 3,325 2,556 3,745 4,107 4,198
Net Income / (Loss) Continuing Operations		 1,548 2,586 2,174 2,558 2,527 2,860 2,338 1,967 2,455 3,049 2,261
Consolidated Net Income / (Loss)		 1,548 2,586 2,174 2,558 2,527 2,860 2,338 1,967 2,455 3,049 2,261
Depreciation Expense		 449 443 475 511 519 539 556 545 567 605 630
Non-Cash Adjustments To Reconcile Net Income		 1,125 -36 137 115 5.00 59 760 848 366 186 1,132
Changes in Operating Assets and Liabilities, net		 -173 148 268 -128 82 261 -329 -804 357 267 175
Net Cash From Investing Activities		 -685 -499 -471 -1,170 -2,099 -779 -592 -1,601 -742 -534 -817
Net Cash From Continuing Investing Activities		 -685 -499 -471 -1,170 -2,099 -779 -592 -1,601 -742 -534 -817
Purchase of Property, Plant & Equipment		 -691 -593 -553 -436 -335 -410 -567 -696 -705 -561 -564
Acquisitions		 -13 -5.00 0.00 -728 -1,711 -353 0.00 -809 0.00 0.00 -293
Purchase of Investments		 -742 -336 -347 -169 -184 -143 -141 -470 -506 -574 -698
Sale and/or Maturity of Investments		 599 378 391 156 131 124 141 322 502 564 752
Other Investing Activities, net		 -68 -3.00 -6.00 7.00 0.00 3.00 -25 5.00 -33 37 -14
Net Cash From Financing Activities		 -2,276 -2,233 -2,450 -2,679 -870 -2,919 -2,774 -952 -2,793 -3,389 -3,256
Net Cash From Continuing Financing Activities		 -2,276 -2,233 -2,450 -2,679 -870 -2,919 -2,774 -952 -2,793 -3,389 -3,256
Repayment of Debt		 -9,181 -7,274 -4,808 -725 -1,426 -564 -898 116 -1,791 -501 -1,512
Repurchase of Common Equity		 -1,551 -1,335 -1,399 -1,238 -1,202 -1,476 -1,320 -1,308 -1,128 -1,739 -1,210
Payment of Dividends		 -1,493 -1,508 -1,529 -1,591 -1,614 -1,753 -1,679 -1,691 -1,749 -1,789 -1,823
Issuance of Debt		 9,602 7,438 4,779 546 2,874 0.00 699 1,513 1,495 2.00 1,188
Other Financing Activities, net		 347 446 507 329 498 874 424 418 380 638 101
Effect of Exchange Rate Changes		 -107 -64 - - -7.00 -16 -15 -60 -19 -54 67
Cash Interest Paid		 131 162 150 194 185 188 194 151 280 302 270
Cash Income Taxes Paid		 1,259 932 1,037 847 803 845 890 945 937 933 913

Quarterly Cash Flow Statements for Colgate-Palmolive

This table details how cash moves in and out of Colgate-Palmolive's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 15 113 31 124 -138 16 103 64 9.00 47 35
Net Cash From Operating Activities		 1,136 681 990 1,167 1,269 600 884 1,261 1,453 747 995
Net Cash From Continuing Operating Activities		 1,136 681 990 1,167 1,269 600 884 1,261 1,453 747 995
Net Income / (Loss) Continuing Operations		 760 729 766 775 779 726 773 767 -5.00 681 720
Consolidated Net Income / (Loss)		 760 729 766 775 779 726 773 767 -5.00 681 720
Depreciation Expense		 150 150 157 150 148 148 151 158 173 156 155
Non-Cash Adjustments To Reconcile Net Income		 19 49 42 71 24 81 26 70 955 205 105
Changes in Operating Assets and Liabilities, net		 207 -247 25 171 318 -355 -66 266 330 -295 15
Net Cash From Investing Activities		 -143 -193 -111 -150 -80 -159 -401 -154 -103 -122 -122
Net Cash From Continuing Investing Activities		 -143 -193 -111 -150 -80 -159 -401 -154 -103 -122 -122
Purchase of Property, Plant & Equipment		 -197 -126 -117 -134 -184 -124 -108 -155 -177 -138 -128
Purchase of Investments		 -182 -139 -104 -115 -216 -134 -250 -153 -161 -70 -54
Sale and/or Maturity of Investments		 238 78 100 82 304 97 253 158 244 94 56
Other Investing Activities, net		 -2.00 -6.00 10 17 16 2.00 -3.00 -297 284 -8.00 4.00
Net Cash From Financing Activities		 -992 -361 -845 -904 -1,279 -458 -409 -1,028 -1,361 -563 -851
Net Cash From Continuing Financing Activities		 -992 -361 -845 -904 -1,279 -458 -409 -1,028 -1,361 -563 -851
Repayment of Debt		 -294 205 -12 -357 -246 192 -225 -338 -1,141 33 -109
Repurchase of Common Equity		 -245 -509 -480 -295 -455 -284 -232 -288 -406 -306 -291
Payment of Dividends		 -506 -394 -473 -408 -514 -406 -474 -420 -523 -417 -462
Other Financing Activities, net		 55 336 119 156 27 40 25 18 18 127 11
Effect of Exchange Rate Changes		 14 -14 -3.00 11 -48 33 29 -15 20 -15 13
Cash Interest Paid		 37 123 38 106 35 109 28 98 35 96 31
Cash Income Taxes Paid		 211 150 355 257 171 139 391 182 201 176 283

Annual Balance Sheets for Colgate-Palmolive

This table presents Colgate-Palmolive's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 11,935 12,123 12,676 12,161 15,034 15,920 15,040 15,731 16,393 16,046 16,330
Total Current Assets		 4,384 4,338 4,639 3,793 4,179 4,338 4,397 5,113 5,279 5,317 5,709
Cash & Equivalents		 970 1,315 1,535 726 883 888 832 775 966 1,096 1,288
Accounts Receivable		 1,427 1,411 1,480 1,400 1,440 1,264 1,297 1,504 1,586 1,521 1,675
Inventories, net		 1,180 1,171 1,221 1,250 1,400 1,673 1,692 2,074 1,934 1,987 2,032
Other Current Assets		 807 441 403 417 456 513 576 760 793 713 714
Plant, Property, & Equipment, net		 3,796 3,840 4,072 3,881 3,750 3,716 3,730 4,307 4,582 4,422 4,660
Plant, Property & Equipment, gross		 - - - - - - - - - - 10,856
Accumulated Depreciation		 - - - - - - - - - - 6,196
Total Noncurrent Assets		 3,755 3,945 3,965 4,487 7,105 7,866 6,913 6,311 6,532 6,307 5,961
Goodwill		 2,103 2,107 2,218 2,530 3,508 3,824 3,284 3,352 3,410 3,272 3,122
Intangible Assets		 1,346 1,313 1,341 1,637 2,667 2,894 2,462 1,920 1,887 1,756 1,536
Noncurrent Deferred & Refundable Income Taxes		 67 301 188 152 177 291 193 135 214 195 205
Other Noncurrent Operating Assets		 239 224 218 168 753 857 974 904 1,021 1,084 1,098
Total Liabilities & Shareholders' Equity		 11,935 12,123 12,676 12,161 15,034 15,920 15,040 15,731 16,393 16,046 16,330
Total Liabilities		 11,979 12,106 12,433 11,964 14,476 14,819 14,069 14,925 15,436 15,502 15,965
Total Current Liabilities		 3,534 3,305 3,408 3,341 4,038 4,404 4,051 4,004 4,741 5,759 6,853
Short-Term Debt		 302 13 11 12 514 267 51 25 330 660 1,117
Accounts Payable		 1,110 1,124 1,212 1,222 1,237 1,393 1,479 1,551 1,698 1,805 2,089
Accrued Expenses		 1,845 1,727 1,831 1,696 1,917 2,341 2,085 2,111 2,377 2,891 3,264
Current Deferred & Payable Income Tax Liabilities		 277 441 354 411 370 403 436 317 336 403 383
Total Noncurrent Liabilities		 8,445 8,801 9,025 8,623 10,438 10,415 10,018 10,921 10,695 9,743 9,112
Long-Term Debt		 6,246 6,520 6,566 6,354 7,333 7,334 7,194 8,741 8,219 7,289 6,871
Noncurrent Deferred & Payable Income Tax Liabilities		 233 246 204 235 507 426 395 383 361 343 181
Other Noncurrent Operating Liabilities		 1,966 2,035 2,255 2,034 2,598 2,655 2,429 1,797 2,115 2,111 2,060
Total Equity & Noncontrolling Interests		 -44 17 243 197 558 1,101 971 806 957 544 365
Total Preferred & Common Equity		 -299 -243 -60 -102 117 743 609 401 609 212 54
Total Common Equity		 -299 -243 -60 -102 117 743 609 401 609 212 54
Common Stock		 2,904 3,157 3,450 3,670 3,954 4,435 4,735 5,012 5,274 5,647 5,788
Retained Earnings		 18,861 19,922 20,531 21,615 22,501 23,699 24,350 24,573 25,289 26,145 26,595
Treasury Stock		 -18,102 -19,135 -20,181 -21,196 -22,063 -23,045 -24,089 -25,128 -26,017 -27,358 -28,450
Accumulated Other Comprehensive Income / (Loss)		 -3,950 -4,180 -3,855 -4,188 -4,273 -4,345 -4,386 -4,055 -3,937 -4,222 -3,879
Noncontrolling Interest		 255 260 303 299 441 358 362 405 348 332 311

Quarterly Balance Sheets for Colgate-Palmolive

This table presents Colgate-Palmolive's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets		 16,043 16,393 16,571 16,480 16,774 16,046 16,647 17,470 17,513 16,610 16,790
Total Current Assets		 5,357 5,279 5,640 5,646 5,806 5,317 5,814 5,996 6,039 6,082 6,308
Cash & Equivalents		 951 966 1,079 1,110 1,234 1,096 1,112 1,215 1,279 1,335 1,370
Accounts Receivable		 1,577 1,586 1,813 1,825 1,712 1,521 1,725 1,773 1,807 1,889 1,962
Inventories, net		 1,931 1,934 1,914 1,922 2,041 1,987 2,125 2,120 2,109 2,086 2,181
Other Current Assets		 898 793 834 789 819 713 852 888 844 772 795
Plant, Property, & Equipment, net		 4,409 4,582 4,497 4,392 4,421 4,422 4,416 4,529 4,560 4,622 4,639
Plant, Property & Equipment, gross		 9,979 - 10,261 10,167 10,238 - 10,276 10,665 10,847 10,887 11,020
Accumulated Depreciation		 5,570 - 5,764 5,775 5,817 - 5,860 6,136 6,287 6,265 6,381
Total Noncurrent Assets		 6,277 6,532 6,434 6,442 6,547 6,307 6,417 6,945 6,914 5,906 5,843
Goodwill		 3,327 3,410 3,341 3,320 3,389 3,272 3,334 3,696 3,702 3,107 3,100
Intangible Assets		 1,861 1,887 1,837 1,814 1,834 1,756 1,782 1,904 1,889 1,521 1,495
Noncurrent Deferred & Refundable Income Taxes		 202 214 222 214 219 195 211 218 216 211 221
Other Noncurrent Operating Assets		 887 1,021 1,034 1,094 1,105 1,084 1,090 1,127 1,107 1,067 1,027
Total Liabilities & Shareholders' Equity		 16,043 16,393 16,571 16,480 16,774 16,046 16,647 17,470 17,513 16,610 16,790
Total Liabilities		 15,637 15,436 15,954 15,998 15,938 15,502 15,914 16,418 16,275 16,124 16,224
Total Current Liabilities		 4,602 4,741 5,314 5,350 5,565 5,759 6,861 6,775 6,496 5,934 6,148
Short-Term Debt		 34 330 538 530 527 660 1,698 1,614 1,113 36 34
Accounts Payable		 1,482 1,698 1,646 1,557 1,625 1,805 1,800 1,790 1,866 2,096 2,115
Accrued Expenses		 2,732 2,377 2,720 2,864 3,066 2,891 2,873 3,050 3,178 3,358 3,589
Current Deferred & Payable Income Tax Liabilities		 354 336 410 399 347 403 490 321 339 444 410
Total Noncurrent Liabilities		 11,035 10,695 10,640 10,648 10,373 9,743 9,053 9,643 9,779 10,190 10,076
Long-Term Debt		 8,690 8,219 8,151 8,146 7,909 7,289 6,571 7,144 7,306 7,937 7,823
Noncurrent Deferred & Payable Income Tax Liabilities		 430 361 392 355 320 343 302 279 304 198 201
Other Noncurrent Operating Liabilities		 1,915 2,115 2,097 2,147 2,144 2,111 2,180 2,220 2,169 2,055 2,052
Total Equity & Noncontrolling Interests		 406 957 617 482 836 544 733 1,052 1,238 486 566
Total Preferred & Common Equity		 -9.00 609 230 123 435 212 363 702 856 145 236
Total Common Equity		 -9.00 609 230 123 435 212 363 702 856 145 236
Common Stock		 5,228 5,274 5,428 5,501 5,608 5,647 5,668 5,712 5,750 5,856 5,898
Retained Earnings		 24,571 25,289 25,164 25,486 25,814 26,145 26,413 26,735 27,051 26,816 27,085
Treasury Stock		 -25,834 -26,017 -26,343 -26,736 -26,913 -27,358 -27,602 -27,821 -28,057 -28,656 -28,931
Accumulated Other Comprehensive Income / (Loss)		 -3,974 -3,937 -4,019 -4,128 -4,074 -4,222 -4,116 -3,924 -3,888 -3,871 -3,816
Noncontrolling Interest		 415 348 387 359 401 332 370 350 382 341 330

Annual Metrics And Ratios for Colgate-Palmolive

This table displays calculated financial ratios and metrics derived from Colgate-Palmolive's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -7.19% -5.23% 1.70% 0.58% 0.96% 4.96% 5.77% 3.13% 8.29% 3.31% 1.40%
EBITDA Growth		 -19.03% 32.18% -2.29% -1.53% -3.72% 9.71% -12.23% -12.05% 24.81% 14.20% -18.91%
EBIT Growth		 -21.59% 37.58% -3.39% -2.70% -4.46% 10.59% -14.41% -13.76% 28.83% 15.37% -22.24%
NOPAT Growth		 -33.65% 75.10% -15.53% 18.03% -0.26% 11.98% -17.17% -15.23% 34.79% 14.08% -25.72%
Net Income Growth		 -33.82% 67.05% -15.93% 17.66% -1.21% 13.18% -18.25% -15.87% 24.81% 24.20% -25.84%
EPS Growth		 -35.59% 78.95% -16.18% 20.61% 0.00% 14.18% -18.79% -16.47% 30.05% 26.71% -25.07%
Operating Cash Flow Growth		 -10.58% 6.51% -2.77% 0.07% 2.52% 18.70% -10.59% -23.13% 46.52% 9.67% 2.22%
Free Cash Flow Firm Growth		 -21.30% 22.75% -25.50% -3.77% -52.40% 165.97% 7.22% -75.41% 332.39% 41.14% -37.38%
Invested Capital Growth		 -14.12% -5.40% 0.96% 10.44% 28.87% 3.88% -5.50% 19.14% -2.92% -13.38% -4.49%
Revenue Q/Q Growth		 -1.97% -1.16% 1.12% -0.52% 1.32% 1.91% 0.46% 1.27% 1.68% -0.02% 1.42%
EBITDA Q/Q Growth		 -25.95% 34.42% -2.47% -3.54% -1.52% -0.68% -14.95% -4.74% 14.32% -1.99% -18.26%
EBIT Q/Q Growth		 -28.91% 39.88% -2.96% -4.15% -1.94% -0.94% -17.12% -5.38% 16.38% -2.22% -21.53%
NOPAT Q/Q Growth		 -41.05% 72.50% -12.92% 12.76% 1.54% 0.68% -17.50% -5.47% 35.11% 0.25% -25.94%
Net Income Q/Q Growth		 -41.25% 68.25% -11.23% 12.79% 1.57% 0.35% -17.73% -6.87% 41.25% 0.56% -25.67%
EPS Q/Q Growth		 -44.73% 76.62% -11.97% 13.64% 1.85% 0.32% -18.79% -6.99% 44.27% 0.86% -26.12%
Operating Cash Flow Q/Q Growth		 -2.16% -0.54% -2.08% 3.49% 3.57% -0.19% 4.49% -14.49% 14.11% 3.35% 4.58%
Free Cash Flow Firm Q/Q Growth		 -21.79% 46.76% -16.03% 1.77% 3.84% -10.66% 13.00% -56.38% 35.47% 29.51% -6.22%
Invested Capital Q/Q Growth		 -6.76% -4.00% -2.38% 2.49% 1.97% 6.75% -4.91% 5.19% 4.41% -7.97% -15.67%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 58.62% 60.04% 60.05% 59.39% 59.42% 60.82% 59.55% 57.04% 58.21% 60.50% 60.11%
EBITDA Margin		 20.19% 28.17% 27.06% 26.49% 25.27% 26.41% 21.92% 18.69% 21.54% 23.81% 19.04%
Operating Margin		 17.39% 26.03% 23.99% 23.76% 22.65% 23.59% 19.13% 16.10% 20.48% 21.23% 16.22%
EBIT Margin		 17.39% 25.25% 23.99% 23.21% 21.96% 23.14% 18.72% 15.66% 18.63% 20.80% 15.95%
Profit (Net Income) Margin		 9.65% 17.02% 14.07% 16.46% 16.10% 17.36% 13.42% 10.95% 12.62% 15.17% 11.09%
Tax Burden Percent		 56.03% 69.18% 62.35% 73.85% 76.55% 78.42% 75.74% 73.95% 72.38% 77.07% 73.91%
Interest Burden Percent		 99.07% 97.42% 94.07% 96.04% 95.79% 95.70% 94.64% 94.56% 93.60% 94.62% 94.09%
Effective Tax Rate		 43.97% 30.82% 37.65% 26.15% 23.45% 21.58% 24.26% 26.05% 27.62% 22.93% 26.09%
Return on Invested Capital (ROIC)		 26.09% 50.81% 43.94% 49.05% 40.73% 39.73% 33.21% 26.44% 33.26% 41.28% 33.79%
ROIC Less NNEP Spread (ROIC-NNEP)		 25.82% 48.03% 41.26% 45.87% 37.66% 37.00% 30.38% 24.05% 27.76% 37.95% 31.10%
Return on Net Nonoperating Assets (RNNOA)		 204.78% -19,206.37% 1,628.37% 1,113.67% 628.67% 305.05% 192.47% 194.94% 245.24% 364.98% 463.68%
Return on Equity (ROE)		 230.87% -19,155.56% 1,672.31% 1,162.73% 669.40% 344.79% 225.68% 221.38% 278.50% 406.26% 497.47%
Cash Return on Invested Capital (CROIC)		 41.29% 56.37% 42.99% 39.13% 15.51% 35.92% 38.87% 8.98% 36.23% 55.62% 38.38%
Operating Return on Assets (OROA)		 21.97% 31.90% 29.90% 29.05% 25.34% 24.62% 21.07% 18.28% 22.56% 25.78% 20.08%
Return on Assets (ROA)		 12.19% 21.50% 17.53% 20.60% 18.58% 18.48% 15.10% 12.78% 15.28% 18.80% 13.97%
Return on Common Equity (ROCE)		 145.65% -384,530.04% -1,948.88% -428.10% 13.30% 178.73% 147.26% 125.83% 159.55% 222.21% 145.57%
Return on Equity Simple (ROE_SIMPLE)		 -517.73% -1,064.20% -3,623.33% -2,507.84% 2,159.83% 384.93% 383.91% 490.52% 403.12% 1,438.21% 0.00%
Net Operating Profit after Tax (NOPAT)		 1,563 2,736 2,311 2,728 2,721 3,047 2,524 2,139 2,883 3,289 2,444
NOPAT Margin		 9.75% 18.01% 14.96% 17.55% 17.34% 18.50% 14.49% 11.91% 14.82% 16.36% 11.99%
Net Nonoperating Expense Percent (NNEP)		 0.27% 2.78% 2.67% 3.18% 3.07% 2.73% 2.83% 2.39% 5.50% 3.33% 2.69%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 22.35% 30.33% 38.73% 29.25%
Cost of Revenue to Revenue		 41.38% 39.96% 39.95% 40.61% 40.58% 39.18% 40.45% 42.96% 41.79% 39.50% 39.89%
SG&A Expenses to Revenue		 34.08% 33.85% 34.94% 34.67% 35.53% 36.54% 36.78% 36.54% 36.75% 38.45% 38.77%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 41.22% 34.01% 36.06% 35.62% 36.77% 37.23% 40.43% 40.94% 37.73% 39.27% 43.89%
Earnings before Interest and Taxes (EBIT)		 2,789 3,837 3,707 3,607 3,446 3,811 3,262 2,813 3,624 4,181 3,251
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 3,238 4,280 4,182 4,118 3,965 4,350 3,818 3,358 4,191 4,786 3,881
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 0.00 455.60 91.25 111.74 155.64 104.85 348.38 1,172.36
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 3.07 3.22 3.69 2.93 3.40 4.12 3.91 3.47 3.28 3.67 3.11
Price to Earnings (P/E)		 35.52 20.05 28.16 18.95 22.52 25.16 31.42 34.96 27.76 25.56 29.69
Dividend Yield		 2.74% 2.82% 2.45% 3.17% 2.75% 2.21% 2.22% 2.49% 2.46% 2.19% 2.62%
Earnings Yield		 2.82% 4.99% 3.55% 5.28% 4.44% 3.98% 3.18% 2.86% 3.60% 3.91% 3.37%
Enterprise Value to Invested Capital (EV/IC)		 9.94 10.39 11.79 8.81 8.07 9.58 10.13 8.05 8.41 10.96 9.95
Enterprise Value to Revenue (EV/Rev)		 3.43 3.58 4.03 3.31 3.87 4.55 4.30 3.94 3.69 4.03 3.45
Enterprise Value to EBITDA (EV/EBITDA)		 16.98 12.71 14.91 12.49 15.31 17.21 19.60 21.09 17.13 16.93 18.12
Enterprise Value to EBIT (EV/EBIT)		 19.72 14.18 16.82 14.26 17.62 19.65 22.94 25.17 19.81 19.38 21.63
Enterprise Value to NOPAT (EV/NOPAT)		 35.20 19.89 26.97 18.85 22.31 24.57 29.65 33.10 24.90 24.64 28.78
Enterprise Value to Operating Cash Flow (EV/OCF)		 18.65 17.32 20.41 16.83 19.38 20.13 22.50 27.70 19.17 19.73 16.75
Enterprise Value to Free Cash Flow (EV/FCFF)		 22.24 17.93 27.57 23.63 58.62 27.18 25.33 97.49 22.86 18.28 25.33
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 -148.82 384.29 27.07 32.31 14.06 6.90 7.46 10.88 8.93 14.61 21.88
Long-Term Debt to Equity		 -141.95 383.53 27.02 32.25 13.14 6.66 7.41 10.84 8.59 13.40 18.82
Financial Leverage		 7.93 -399.85 39.46 24.28 16.69 8.24 6.33 8.11 8.83 9.62 14.91
Leverage Ratio		 18.94 -891.04 95.38 56.45 36.02 18.66 14.94 17.32 18.22 21.61 35.62
Compound Leverage Factor		 18.76 -868.05 89.72 54.21 34.50 17.86 14.14 16.37 17.05 20.45 33.51
Debt to Total Capital		 100.68% 99.74% 96.44% 97.00% 93.36% 87.35% 88.18% 91.58% 89.93% 93.59% 95.63%
Short-Term Debt to Total Capital		 4.64% 0.20% 0.16% 0.18% 6.12% 3.07% 0.62% 0.26% 3.47% 7.77% 13.37%
Long-Term Debt to Total Capital		 96.03% 99.54% 96.28% 96.82% 87.25% 84.28% 87.56% 91.32% 86.46% 85.82% 82.26%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 3.92% 3.97% 4.44% 4.56% 5.25% 4.11% 4.41% 4.23% 3.66% 3.91% 3.72%
Common Equity to Total Capital		 -4.60% -3.71% -0.88% -1.55% 1.39% 8.54% 7.41% 4.19% 6.41% 2.50% 0.65%
Debt to EBITDA		 2.02 1.53 1.57 1.55 1.98 1.75 1.90 2.61 2.04 1.66 2.06
Net Debt to EBITDA		 1.72 1.22 1.21 1.37 1.76 1.54 1.68 2.38 1.81 1.43 1.73
Long-Term Debt to EBITDA		 1.93 1.52 1.57 1.54 1.85 1.69 1.88 2.60 1.96 1.52 1.77
Debt to NOPAT		 4.19 2.39 2.85 2.33 2.88 2.49 2.87 4.10 2.96 2.42 3.27
Net Debt to NOPAT		 3.57 1.91 2.18 2.07 2.56 2.20 2.54 3.74 2.63 2.08 2.74
Long-Term Debt to NOPAT		 4.00 2.38 2.84 2.33 2.70 2.41 2.85 4.09 2.85 2.22 2.81
Altman Z-Score		 6.87 7.13 7.32 7.07 6.12 6.65 7.07 6.51 6.60 7.22 6.48
Noncontrolling Interest Sharing Ratio		 36.91% -1,907.41% 216.54% 136.82% 98.01% 48.16% 34.75% 43.16% 42.71% 45.30% 70.74%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.24 1.31 1.36 1.14 1.03 0.99 1.09 1.28 1.11 0.92 0.83
Quick Ratio		 0.68 0.82 0.88 0.64 0.58 0.49 0.53 0.57 0.54 0.45 0.43
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 2,473 3,035 2,261 2,176 1,036 2,755 2,954 726 3,140 4,432 2,776
Operating Cash Flow to CapEx		 426.77% 589.31% 552.26% 700.92% 935.22% 907.07% 586.42% 393.84% 531.21% 732.09% 744.33%
Free Cash Flow to Firm to Interest Expense		 95.10 30.66 10.28 15.22 7.14 16.80 16.88 4.35 10.94 15.18 10.40
Operating Cash Flow to Interest Expense		 113.42 31.73 13.88 21.37 21.61 22.68 19.00 15.31 13.05 14.07 15.72
Operating Cash Flow Less CapEx to Interest Expense		 86.85 26.34 11.37 18.32 19.30 20.18 15.76 11.42 10.59 12.14 13.61
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.26 1.26 1.25 1.25 1.15 1.06 1.13 1.17 1.21 1.24 1.26
Accounts Receivable Turnover		 10.76 10.71 10.69 10.79 11.05 12.18 13.60 12.83 12.59 12.94 12.75
Inventory Turnover		 5.18 5.17 5.16 5.11 4.81 4.20 4.19 4.10 4.06 4.05 4.05
Fixed Asset Turnover		 4.07 3.98 3.91 3.91 4.11 4.41 4.68 4.47 4.38 4.46 4.49
Accounts Payable Turnover		 5.67 5.44 5.29 5.19 5.18 4.91 4.91 5.10 5.01 4.53 4.18
Days Sales Outstanding (DSO)		 33.91 34.09 34.14 33.81 33.03 29.96 26.83 28.45 28.98 28.21 28.62
Days Inventory Outstanding (DIO)		 70.47 70.66 70.71 71.43 75.95 86.90 87.16 89.04 89.96 90.12 90.21
Days Payable Outstanding (DPO)		 64.39 67.15 69.05 70.36 70.47 74.37 74.39 71.64 72.92 80.52 87.40
Cash Conversion Cycle (CCC)		 39.99 37.60 35.80 34.88 38.50 42.49 39.60 45.85 46.02 37.82 31.42
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 5,534 5,235 5,285 5,837 7,522 7,814 7,384 8,797 8,540 7,397 7,065
Invested Capital Turnover		 2.68 2.82 2.94 2.80 2.35 2.15 2.29 2.22 2.24 2.52 2.82
Increase / (Decrease) in Invested Capital		 -910 -299 50 552 1,685 292 -430 1,413 -257 -1,143 -332
Enterprise Value (EV)		 54,996 54,412 62,334 51,425 60,710 74,869 74,828 70,806 71,784 81,041 70,319
Market Capitalization		 49,163 48,934 56,989 45,486 53,305 67,798 68,053 62,410 63,853 73,856 63,308
Book Value per Share		 ($0.33) ($0.27) ($0.07) ($0.12) $0.14 $0.87 $0.72 $0.48 $0.74 $0.26 $0.07
Tangible Book Value per Share		 ($4.18) ($4.12) ($4.12) ($4.92) ($7.07) ($6.97) ($6.09) ($5.83) ($5.69) ($5.89) ($5.71)
Total Capital		 6,504 6,550 6,820 6,563 8,405 8,702 8,216 9,572 9,506 8,493 8,353
Total Debt		 6,548 6,533 6,577 6,366 7,847 7,601 7,245 8,766 8,549 7,949 7,988
Total Long-Term Debt		 6,246 6,520 6,566 6,354 7,333 7,334 7,194 8,741 8,219 7,289 6,871
Net Debt		 5,578 5,218 5,042 5,640 6,964 6,713 6,413 7,991 7,583 6,853 6,700
Capital Expenditures (CapEx)		 691 533 553 436 335 410 567 649 705 561 564
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 182 -269 -293 -262 -228 -687 -435 359 -98 -878 -1,315
Debt-free Net Working Capital (DFNWC)		 1,152 1,046 1,242 464 655 201 397 1,134 868 218 -27
Net Working Capital (NWC)		 850 1,033 1,231 452 141 -66 346 1,109 538 -442 -1,144
Net Nonoperating Expense (NNE)		 15 150 137 170 194 187 186 172 428 240 183
Net Nonoperating Obligations (NNO)		 5,578 5,218 5,042 5,640 6,964 6,713 6,413 7,991 7,583 6,853 6,700
Total Depreciation and Amortization (D&A)		 449 443 475 511 519 539 556 545 567 605 630
Debt-free, Cash-free Net Working Capital to Revenue		 1.14% -1.77% -1.90% -1.69% -1.45% -4.17% -2.50% 2.00% -0.50% -4.37% -6.45%
Debt-free Net Working Capital to Revenue		 7.18% 6.88% 8.04% 2.99% 4.17% 1.22% 2.28% 6.31% 4.46% 1.08% -0.13%
Net Working Capital to Revenue		 5.30% 6.80% 7.97% 2.91% 0.90% -0.40% 1.99% 6.17% 2.77% -2.20% -5.61%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.53 $2.74 $0.00 $2.76 $2.76 $3.15 $2.56 $2.13 $2.78 $3.53 $2.64
Adjusted Weighted Average Basic Shares Outstanding		 892.74M 882.86M 0.00 861.68M 855.03M 848.56M 840.49M 830.38M 823.15M 811.54M 801.55M
Adjusted Diluted Earnings per Share		 $1.52 $2.72 $0.00 $2.75 $2.75 $3.14 $2.55 $2.13 $2.77 $3.51 $2.63
Adjusted Weighted Average Diluted Shares Outstanding		 892.74M 882.86M 0.00 861.68M 855.03M 848.56M 840.49M 830.38M 823.15M 811.54M 801.55M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 892.74M 882.86M 0.00 861.68M 855.03M 848.56M 840.49M 830.38M 823.15M 811.54M 801.55M
Normalized Net Operating Profit after Tax (NOPAT)		 1,563 2,736 2,311 2,728 2,721 3,047 2,956 2,672 2,883 3,289 3,123
Normalized NOPAT Margin		 9.75% 18.01% 14.96% 17.55% 17.34% 18.50% 16.97% 14.87% 14.82% 16.36% 15.32%
Pre Tax Income Margin		 17.23% 24.60% 22.56% 22.29% 21.03% 22.14% 17.72% 14.80% 17.43% 19.68% 15.01%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 107.27 38.76 16.85 25.22 23.77 23.24 18.64 16.84 12.63 14.32 12.18
NOPAT to Interest Expense		 60.10 27.64 10.51 19.08 18.76 18.58 14.42 12.81 10.05 11.27 9.15
EBIT Less CapEx to Interest Expense		 80.69 33.37 14.34 22.17 21.46 20.74 15.40 12.96 10.17 12.40 10.06
NOPAT Less CapEx to Interest Expense		 33.52 22.25 7.99 16.03 16.45 16.08 11.18 8.92 7.59 9.34 7.04
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 96.45% 58.31% 70.33% 62.20% 63.87% 61.29% 71.81% 85.97% 71.24% 58.68% 80.63%
Augmented Payout Ratio		 196.64% 109.94% 134.68% 110.59% 111.44% 112.90% 128.27% 152.47% 117.19% 115.71% 134.14%

Quarterly Metrics And Ratios for Colgate-Palmolive

This table displays calculated financial ratios and metrics derived from Colgate-Palmolive's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 - - - - - - - - - 800,189,310.00 797,172,829.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - 800,189,310.00 797,172,829.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - 0.81 0.87
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 6.93% 6.18% 4.89% 2.40% -0.10% -3.04% 1.03% 1.95% 5.76% 8.41% 4.91%
EBITDA Growth		 279.50% 58.14% 11.62% 4.92% -0.82% -1.96% -1.55% 0.34% -72.73% -5.03% -4.80%
EBIT Growth		 473.26% 66.67% 12.12% 5.03% -0.75% -2.05% -1.22% -0.38% -85.44% -6.57% -5.87%
NOPAT Growth		 1,153.16% 17.66% 41.42% 4.25% 0.96% 3.85% -0.03% -2.44% -100.41% -10.22% -7.25%
Net Income Growth		 1,667.44% 76.09% 43.63% 3.88% 2.24% -0.41% 0.78% -1.29% -100.51% -6.20% -6.99%
EPS Growth		 8,500.00% 84.44% 48.33% 4.65% 3.49% 2.41% 2.25% 1.11% -104.49% -5.88% -5.49%
Operating Cash Flow Growth		 68.80% -7.35% 37.12% 1.30% 11.71% -11.89% -10.71% 8.05% 14.50% 24.50% 12.56%
Free Cash Flow Firm Growth		 180.29% 405.58% 695.55% -0.90% 82.65% 12.60% -77.73% -51.21% -83.37% 29.85% 719.38%
Invested Capital Growth		 -2.92% -2.81% -5.15% -1.72% -13.38% -4.10% 6.80% 4.23% -4.49% -9.71% -17.94%
Revenue Q/Q Growth		 0.71% 2.32% -0.14% -0.49% -1.75% -0.69% 4.05% 0.41% 1.93% 1.80% 0.70%
EBITDA Q/Q Growth		 5.53% -2.08% 6.30% -2.72% -0.25% -4.95% 4.86% -0.99% -72.83% 236.62% 5.12%
EBIT Q/Q Growth		 5.72% -2.38% 6.54% -2.47% -0.09% -5.64% 5.28% -1.80% -85.36% 517.11% 6.08%
NOPAT Q/Q Growth		 2.56% -4.28% 5.06% 1.07% -0.67% -1.54% 1.14% -1.36% -100.42% 21,734.24% 4.48%
Net Income Q/Q Growth		 1.74% -4.08% 5.21% 1.17% 0.13% -6.56% 6.47% -0.91% -100.52% 17,125.00% 5.58%
EPS Q/Q Growth		 0.00% -3.49% 7.23% 1.12% -1.11% -4.49% 7.06% 0.00% -104.40% 2,100.00% 7.50%
Operating Cash Flow Q/Q Growth		 -1.39% -40.05% 45.37% 17.88% 8.74% -52.72% 47.33% 42.65% 15.23% -48.59% 33.20%
Free Cash Flow Firm Q/Q Growth		 9.47% -5.02% 23.26% -22.67% 101.76% -41.45% -75.62% 69.39% -31.22% 357.08% 53.86%
Invested Capital Q/Q Growth		 4.41% -3.67% -2.18% -0.12% -7.97% 6.66% 8.94% -2.52% -15.67% 0.84% -1.00%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 59.60% 60.00% 60.62% 61.08% 60.30% 60.82% 60.06% 59.42% 60.15% 60.59% 61.48%
EBITDA Margin		 24.69% 23.20% 24.69% 24.14% 24.51% 23.46% 23.64% 23.31% 6.21% 20.55% 21.45%
Operating Margin		 21.66% 20.67% 21.59% 21.16% 21.52% 21.91% 21.14% 20.64% 1.74% 18.11% 18.95%
EBIT Margin		 21.66% 20.24% 21.59% 21.16% 21.52% 20.44% 20.68% 20.23% 2.91% 17.62% 18.56%
Profit (Net Income) Margin		 15.35% 14.39% 15.16% 15.42% 15.71% 14.78% 15.13% 14.93% -0.08% 12.79% 13.41%
Tax Burden Percent		 76.92% 75.39% 75.94% 78.70% 78.25% 76.18% 76.76% 77.22% -3.74% 76.35% 75.68%
Interest Burden Percent		 92.16% 94.34% 92.49% 92.58% 93.33% 94.92% 95.27% 95.57% 70.39% 95.10% 95.48%
Effective Tax Rate		 23.08% 24.61% 24.06% 21.30% 21.75% 23.82% 23.24% 22.78% 103.74% 23.65% 24.32%
Return on Invested Capital (ROIC)		 37.39% 36.88% 39.64% 41.29% 42.47% 41.32% 38.99% 39.02% -0.18% 38.29% 38.58%
ROIC Less NNEP Spread (ROIC-NNEP)		 36.56% 36.11% 38.85% 40.46% 41.70% 40.05% 38.25% 38.30% -0.19% 37.50% 37.87%
Return on Net Nonoperating Assets (RNNOA)		 322.98% 542.34% 767.08% 487.88% 401.06% 438.04% 376.73% 264.85% -2.87% 424.32% 328.38%
Return on Equity (ROE)		 360.38% 579.23% 806.73% 529.18% 443.53% 479.36% 415.72% 303.87% -3.05% 462.62% 366.97%
Cash Return on Invested Capital (CROIC)		 36.23% 38.87% 44.57% 42.21% 55.62% 45.38% 33.32% 36.06% 38.38% 41.65% 49.12%
Operating Return on Assets (OROA)		 26.23% 24.41% 26.39% 25.93% 26.67% 24.55% 24.37% 23.72% 3.66% 22.03% 22.80%
Return on Assets (ROA)		 18.60% 17.36% 18.53% 18.89% 19.47% 17.75% 17.82% 17.50% -0.10% 16.00% 16.48%
Return on Common Equity (ROCE)		 206.45% 124.52% 59.72% 181.51% 242.60% 210.56% 223.58% 189.15% -0.89% 192.79% 212.74%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 1,204.35% 2,441.46% 697.01% 0.00% 839.12% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 825 789 829 838 833 820 829 818 -3.40 736 769
NOPAT Margin		 16.66% 15.58% 16.40% 16.65% 16.84% 16.69% 16.22% 15.94% -0.07% 13.82% 14.34%
Net Nonoperating Expense Percent (NNEP)		 0.83% 0.77% 0.79% 0.83% 0.77% 1.27% 0.74% 0.72% 0.01% 0.80% 0.71%
Return On Investment Capital (ROIC_SIMPLE)		 8.67% - - - 9.80% 9.11% 8.45% 8.47% -0.04% 8.70% 9.13%
Cost of Revenue to Revenue		 40.40% 40.00% 39.38% 38.92% 39.70% 39.18% 39.94% 40.58% 39.85% 39.41% 38.52%
SG&A Expenses to Revenue		 36.42% 37.83% 38.34% 39.32% 38.32% 38.65% 38.41% 38.41% 39.60% 38.99% 39.73%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 37.94% 39.33% 39.03% 39.92% 38.79% 38.91% 38.92% 38.78% 58.41% 42.49% 42.53%
Earnings before Interest and Taxes (EBIT)		 1,072 1,025 1,092 1,065 1,064 1,004 1,057 1,038 152 938 995
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 1,222 1,175 1,249 1,215 1,212 1,152 1,208 1,196 325 1,094 1,150
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 104.85 320.51 644.00 194.02 348.38 208.31 104.31 74.98 1,172.36 468.23 309.08
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 3.28 3.73 3.96 4.20 3.67 3.79 3.66 3.19 3.11 3.26 3.47
Price to Earnings (P/E)		 27.76 28.23 27.89 29.42 25.56 26.11 25.18 22.09 29.69 32.52 35.79
Dividend Yield		 2.46% 2.14% 2.01% 1.90% 2.19% 2.15% 2.24% 2.57% 2.62% 2.46% 2.29%
Earnings Yield		 3.60% 3.54% 3.59% 3.40% 3.91% 3.83% 3.97% 4.53% 3.37% 3.08% 2.79%
Enterprise Value to Invested Capital (EV/IC)		 8.41 9.93 10.83 11.45 10.96 10.54 9.44 8.56 9.95 10.51 11.31
Enterprise Value to Revenue (EV/Rev)		 3.69 4.14 4.36 4.58 4.03 4.17 4.06 3.57 3.45 3.60 3.79
Enterprise Value to EBITDA (EV/EBITDA)		 17.13 17.68 18.00 18.84 16.93 17.46 17.10 15.10 18.12 19.58 21.18
Enterprise Value to EBIT (EV/EBIT)		 19.81 20.26 20.55 21.52 19.38 19.99 19.56 17.31 21.63 23.51 25.54
Enterprise Value to NOPAT (EV/NOPAT)		 24.90 27.18 26.83 28.04 24.64 25.04 24.43 21.73 28.78 31.71 34.66
Enterprise Value to Operating Cash Flow (EV/OCF)		 19.17 22.14 22.01 23.15 19.73 20.65 20.69 17.86 16.75 17.23 17.90
Enterprise Value to Free Cash Flow (EV/FCFF)		 22.86 25.19 23.65 26.88 18.28 22.73 29.25 24.23 25.33 23.95 20.76
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 8.93 14.08 18.00 10.09 14.61 11.28 8.33 6.80 21.88 16.41 13.88
Long-Term Debt to Equity		 8.59 13.21 16.90 9.46 13.40 8.96 6.79 5.90 18.82 16.33 13.82
Financial Leverage		 8.83 15.02 19.74 12.06 9.62 10.94 9.85 6.92 14.91 11.32 8.67
Leverage Ratio		 18.22 31.42 41.04 26.42 21.61 24.61 22.13 16.53 35.62 27.28 21.17
Compound Leverage Factor		 16.79 29.65 37.96 24.46 20.17 23.36 21.08 15.80 25.07 25.94 20.22
Debt to Total Capital		 89.93% 93.37% 94.74% 90.98% 93.59% 91.86% 89.28% 87.18% 95.63% 94.25% 93.28%
Short-Term Debt to Total Capital		 3.47% 5.78% 5.79% 5.68% 7.77% 18.86% 16.45% 11.53% 13.37% 0.43% 0.40%
Long-Term Debt to Total Capital		 86.46% 87.59% 88.95% 85.30% 85.82% 72.99% 72.82% 75.66% 82.26% 93.83% 92.88%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 3.66% 4.16% 3.92% 4.32% 3.91% 4.11% 3.57% 3.96% 3.72% 4.03% 3.92%
Common Equity to Total Capital		 6.41% 2.47% 1.34% 4.69% 2.50% 4.03% 7.16% 8.86% 0.65% 1.71% 2.80%
Debt to EBITDA		 2.04 1.88 1.79 1.73 1.66 1.74 1.85 1.77 2.06 2.09 2.09
Net Debt to EBITDA		 1.81 1.65 1.56 1.47 1.43 1.50 1.59 1.50 1.73 1.74 1.72
Long-Term Debt to EBITDA		 1.96 1.76 1.68 1.62 1.52 1.38 1.51 1.54 1.77 2.08 2.08
Debt to NOPAT		 2.96 2.89 2.67 2.57 2.42 2.49 2.64 2.55 3.27 3.38 3.41
Net Debt to NOPAT		 2.63 2.53 2.33 2.19 2.08 2.16 2.27 2.16 2.74 2.81 2.82
Long-Term Debt to NOPAT		 2.85 2.71 2.51 2.41 2.22 1.98 2.15 2.21 2.81 3.36 3.40
Altman Z-Score		 6.08 6.32 6.59 6.76 6.58 6.39 6.11 5.84 5.85 6.24 6.42
Noncontrolling Interest Sharing Ratio		 42.71% 78.50% 92.60% 65.70% 45.30% 56.07% 46.22% 37.75% 70.74% 58.33% 42.03%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.11 1.06 1.06 1.04 0.92 0.85 0.89 0.93 0.83 1.02 1.03
Quick Ratio		 0.54 0.54 0.55 0.53 0.45 0.41 0.44 0.48 0.43 0.54 0.54
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 1,082 1,027 1,266 979 1,976 1,157 282 478 329 1,502 2,311
Operating Cash Flow to CapEx		 576.65% 540.48% 846.15% 870.90% 689.67% 483.87% 818.52% 813.55% 820.90% 541.30% 777.34%
Free Cash Flow to Firm to Interest Expense		 0.00 17.71 57.56 42.57 10.45 17.53 3.97 7.13 5.22 24.23 37.27
Operating Cash Flow to Interest Expense		 0.00 11.74 45.00 50.74 6.71 9.09 12.45 18.82 23.06 12.05 16.05
Operating Cash Flow Less CapEx to Interest Expense		 0.00 9.57 39.68 44.91 5.74 7.21 10.93 16.51 20.25 9.82 13.98
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.21 1.21 1.22 1.23 1.24 1.20 1.18 1.17 1.26 1.25 1.23
Accounts Receivable Turnover		 12.59 11.61 11.48 12.23 12.94 11.28 11.12 11.42 12.75 11.51 11.27
Inventory Turnover		 4.06 4.03 4.07 4.02 4.05 3.88 3.90 3.86 4.05 3.94 3.87
Fixed Asset Turnover		 4.38 4.46 4.53 4.55 4.46 4.48 4.48 4.48 4.49 4.60 4.59
Accounts Payable Turnover		 5.01 4.98 5.20 5.13 4.53 4.55 4.71 4.59 4.18 4.26 4.27
Days Sales Outstanding (DSO)		 28.98 31.44 31.78 29.85 28.21 32.37 32.83 31.96 28.62 31.72 32.39
Days Inventory Outstanding (DIO)		 89.96 90.68 89.73 90.87 90.12 94.04 93.53 94.55 90.21 92.54 94.24
Days Payable Outstanding (DPO)		 72.92 73.35 70.25 71.08 80.52 80.24 77.45 79.54 87.40 85.61 85.56
Cash Conversion Cycle (CCC)		 46.02 48.77 51.27 49.64 37.82 46.18 48.92 46.97 31.42 38.64 41.06
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 8,540 8,227 8,048 8,038 7,397 7,890 8,595 8,378 7,065 7,124 7,053
Invested Capital Turnover		 2.24 2.37 2.42 2.48 2.52 2.48 2.40 2.45 2.82 2.77 2.69
Increase / (Decrease) in Invested Capital		 -257 -238 -437 -141 -1,143 -337 547 340 -332 -766 -1,542
Enterprise Value (EV)		 71,784 81,714 87,137 92,003 81,041 83,145 81,121 71,701 70,319 74,873 79,760
Market Capitalization		 63,853 73,717 79,212 84,400 73,856 75,618 73,228 64,179 63,308 67,894 72,943
Book Value per Share		 $0.74 $0.28 $0.15 $0.53 $0.26 $0.45 $0.87 $1.06 $0.07 $0.18 $0.29
Tangible Book Value per Share		 ($5.69) ($6.03) ($6.11) ($5.86) ($5.89) ($5.86) ($6.04) ($5.86) ($5.71) ($5.59) ($5.45)
Total Capital		 9,506 9,306 9,158 9,272 8,493 9,002 9,810 9,657 8,353 8,459 8,423
Total Debt		 8,549 8,689 8,676 8,436 7,949 8,269 8,758 8,419 7,988 7,973 7,857
Total Long-Term Debt		 8,219 8,151 8,146 7,909 7,289 6,571 7,144 7,306 6,871 7,937 7,823
Net Debt		 7,583 7,610 7,566 7,202 6,853 7,157 7,543 7,140 6,700 6,638 6,487
Capital Expenditures (CapEx)		 197 126 117 134 184 124 108 155 177 138 128
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -98 -215 -284 -466 -878 -461 -380 -623 -1,315 -1,151 -1,176
Debt-free Net Working Capital (DFNWC)		 868 864 826 768 218 651 835 656 -27 184 194
Net Working Capital (NWC)		 538 326 296 241 -442 -1,047 -779 -457 -1,144 148 160
Net Nonoperating Expense (NNE)		 65 60 62 62 56 94 56 52 0.60 55 50
Net Nonoperating Obligations (NNO)		 7,583 7,610 7,566 7,202 6,853 7,157 7,543 7,140 6,700 6,638 6,487
Total Depreciation and Amortization (D&A)		 150 150 157 150 148 148 151 158 173 156 155
Debt-free, Cash-free Net Working Capital to Revenue		 -0.50% -1.09% -1.42% -2.32% -4.37% -2.31% -1.90% -3.10% -6.45% -5.54% -5.59%
Debt-free Net Working Capital to Revenue		 4.46% 4.37% 4.13% 3.82% 1.08% 3.26% 4.18% 3.26% -0.13% 0.88% 0.92%
Net Working Capital to Revenue		 2.77% 1.65% 1.48% 1.20% -2.20% -5.25% -3.90% -2.27% -5.61% 0.71% 0.76%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.86 $0.83 $0.89 $0.90 $0.91 $0.85 $0.92 $0.91 ($0.04) $0.81 $0.87
Adjusted Weighted Average Basic Shares Outstanding		 823.15M 820.44M 817.09M 817.01M 811.54M 810.42M 808.22M 806.06M 801.55M 800.19M 797.17M
Adjusted Diluted Earnings per Share		 $0.86 $0.83 $0.89 $0.90 $0.89 $0.85 $0.91 $0.91 ($0.04) $0.80 $0.86
Adjusted Weighted Average Diluted Shares Outstanding		 823.15M 820.44M 817.09M 817.01M 811.54M 810.42M 808.22M 806.06M 801.55M 800.19M 797.17M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 823.15M 820.44M 817.09M 817.01M 811.54M 810.42M 808.22M 806.06M 801.55M 800.19M 797.17M
Normalized Net Operating Profit after Tax (NOPAT)		 825 789 829 838 833 820 829 818 64 736 769
Normalized NOPAT Margin		 16.66% 15.58% 16.40% 16.65% 16.84% 16.69% 16.22% 15.94% 1.22% 13.82% 14.34%
Pre Tax Income Margin		 19.96% 19.09% 19.97% 19.59% 20.08% 19.41% 19.71% 19.33% 2.05% 16.75% 17.72%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 17.67 49.64 46.30 5.63 15.21 14.89 15.49 2.41 15.13 16.05
NOPAT to Interest Expense		 0.00 13.61 37.69 36.44 4.41 12.42 11.68 12.21 -0.05 11.87 12.40
EBIT Less CapEx to Interest Expense		 0.00 15.50 44.32 40.48 4.66 13.33 13.37 13.18 -0.40 12.90 13.98
NOPAT Less CapEx to Interest Expense		 0.00 11.44 32.38 30.62 3.43 10.54 10.16 9.89 -2.86 9.64 10.34
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 71.24% 63.29% 58.91% 58.74% 58.68% 59.13% 59.04% 59.63% 80.63% 82.76% 84.27%
Augmented Payout Ratio		 117.19% 115.88% 111.06% 109.17% 115.71% 108.83% 100.52% 101.02% 134.14% 138.36% 143.99%

Financials Breakdown Chart

Key Financial Trends

Colgate-Palmolive’s latest quarter shows a business that is still generating strong revenue and cash flow, but the balance sheet has become much more stretched over the last year. Profitability improved sharply from the weak Q4 2025 result, and operating cash flow remains healthy, yet leverage and working-capital pressure deserve attention.

  • Revenue growth resumed in Q1 2026. Total revenue rose to $5.32 billion from $5.23 billion in Q4 2025 and $4.91 billion in Q1 2025, showing the company can still grow sales steadily.
  • Gross profit and operating income improved quarter over quarter. Q1 2026 gross profit was $3.23 billion and operating income was $964 million, both much better than the prior quarter.
  • Margins remain resilient for a consumer staples company. Q1 2026 gross margin was about 60.6% and operating margin was about 18.1%, which is solid.
  • Operating cash flow remained strong. Q1 2026 net cash from operations was $747 million, indicating the business still converts earnings into cash.
  • Dividend coverage appears manageable from a cash-flow standpoint. The company paid $0.53 per share in dividends in Q1 2026 while still generating positive operating cash flow.
  • Quarterly earnings were lower than a year ago, but still healthy. Q1 2026 diluted EPS was $0.80 versus $0.85 in Q1 2025, so earnings growth is not yet accelerating.
  • Share count is edging lower. Weighted average diluted shares fell to about 800.2 million in Q1 2026 from about 810.4 million in Q1 2025, which helps support per-share results.
  • Balance sheet leverage is high. Total liabilities were $16.12 billion versus only $486 million of total equity and noncontrolling interests in Q1 2026, leaving a very thin equity cushion.
  • Equity remains extremely small because of large treasury stock and AOCI balances. Common equity was just $145 million in Q1 2026, suggesting the balance sheet is heavily burdened by buybacks and accumulated losses in equity accounts.
  • Debt levels are still significant. Long-term debt was $7.94 billion and short-term debt was $36 million in Q1 2026, while current liabilities also exceeded current assets.

Looking at the longer trend, Colgate has generally produced dependable revenue and earnings, but the recent period shows some pressure from rising operating expenses, interest costs, and a balance sheet that is far more leveraged than the income statement alone would suggest. The company’s core consumer staples profile still supports cash generation, but investors should watch whether earnings growth can re-accelerate and whether debt continues to come down.

08/18/26 05:29 AM ETAI Generated. May Contain Errors.

Colgate-Palmolive Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Colgate-Palmolive's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Colgate-Palmolive's net income for the last 5 years looks like this:
  • 2021: $2.34 billion
  • 2022: $1.97 billion
  • 2023: $2.46 billion
  • 2024: $3.05 billion
  • 2025: $2.26 billion
See Colgate-Palmolive's forecast for analyst expectations on what's next for the company.

Colgate-Palmolive's total operating income in 2025 was $3.31 billion, based on the following breakdown:
  • Total Gross Profit: $12.25 billion
  • Total Operating Expenses: $8.95 billion

Over the last 10 years, Colgate-Palmolive's total revenue changed from $16.03 billion in 2015 to $20.38 billion in 2025, a change of 27.1%.

Colgate-Palmolive's total liabilities were at $15.97 billion at the end of 2025, a 3.0% increase from 2024, and a 33.3% increase since 2015.

In the past 10 years, Colgate-Palmolive's cash and equivalents has ranged from $726 million in 2018 to $1.54 billion in 2017, and is currently $1.29 billion as of their latest financial filing in 2025.

Over the last 10 years, Colgate-Palmolive's book value per share changed from -0.33 in 2015 to 0.07 in 2025, a change of -120.1%.


Related Companies

Financial statements for NYSE:CL last updated on 7/31/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
The retirement stock I'd buy before Nvidia today
In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...
Chaikin Analytics | Sponsoredtc pixel
Iran War: What Happened at 1:11 P.M. Outside D.C.?
A source with ties to Saudi Arabia, the UAE, and the U.S. State Department revealed details of a potential 7 t...
Banyan Hill Publishing | Sponsoredtc pixel
Gold Miners Post Record Cash Flow Even as Prices Pull Back
The four largest gold miners are generating record free cash flow, even with gold pulling back from recent hig...
Golden Portfolio | Sponsoredtc pixel
Musk says UBI is coming. I say it's already here.
Elon Musk says AI could make money irrelevant by 2036. One income program already exists today, funded not by ...
Freedom Financial | Sponsoredtc pixel
The trade I’ve been waiting for since 2011
Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...
Traders Agency | Sponsoredtc pixel
A Wall Street veteran shares two simple trading rules
A self-described Market Wizard says two simple rules, refined over decades on Wall Street, form the basis of h...
Brownstone Research | Sponsoredtc pixel
19 Factories. One AI Brain. One Hidden Stock.
A little-known aerospace manufacturer has linked 19 factories worldwide into a single AI-ready data system, dr...
The Oxford Club | Sponsoredtc pixel
Someone just dumped the biggest gold fund.
Investors pulled 2.9 billion dollars from the world's largest gold fund in a single day this March, pushing to...
Behind the Markets | Sponsoredtc pixel